Study #2025-0589
NRG-BN013: Phase III trial of single fraction stereotactic radiosurgery (SRS) versus fractionated SRS (FSRS) for intact brain metastases
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Anatomic Stage IV Breast Cancer AJCC v8;Metastatic Breast Carcinoma;Metastatic Digestive System Carcinoma;Metastatic Lung Non-Small Cell Carcinoma;Metastatic Malignant Neoplasm in the Brain;Metastatic Malignant Solid Neoplasm;Metastatic Melanoma;Metastatic Renal Cell Carcinoma;Stage IV Lung Cancer AJCC v8;Stage IV Renal Cell Cancer AJCC v8
Study phase:
Phase III
Physician name:
Martin Tom
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.